Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Cancer researchers, clinicians, and the public are increasingly interested in statistical models designed to predict the occurrence of cancer. As the number and sophistication of cancer risk prediction models have grown, so too has interest in ensuring that they are appropriately applied, correctly developed, and rigorously evaluated. On May 20-21, 2004, the National Cancer Institute sponsored a workshop in which experts identified strengths and limitations of cancer and genetic susceptibility prediction models that were currently in use and under development and explored methodologic issues related to their development, evaluation, and validation. Participants also identified research priorities and resources in the areas of 1) revising existing breast cancer risk assessment models and developing new models, 2) encouraging the development of new risk models, 3) obtaining data to develop more accurate risk models, 4) supporting validation mechanisms and resources, 5) strengthening model development efforts and encouraging coordination, and 6) promoting effective cancer risk communication and decision-making.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
Self-citationD'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
A breast cancer prediction model incorporating familial and personal risk factors
Tyrer, J., Duffy, S. W., & Cuzick, J. (2004) · Statistics in Medicine · doi:10.1002/sim.1668 · Cited by 1,345
A general cardiovascular risk profile: The Framingham study
Kannel, W. B., McGee, D., & Gordon, T. (1976) · The American Journal of Cardiology · doi:10.1016/0002-9149(76)90061-8 · Cited by 1,189
Assessment and comparison of prognostic classification schemes for survival data
Graf, E., Schmoor, C., Sauerbrei, W., & Schumacher, M. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990915/30)18:17/18<2529::aid-sim274>3.0.co;2-5 · Cited by 975
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction
Claus, E. B., Risch, N., & Thompson, W. D. (1994) · Cancer · doi:10.1002/1097-0142(19940201)73:3<643::aid-cncr2820730323>3.0.co;2-5 · Cited by 942
Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., & Stratton, M. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 873
Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer Incidence
Costantino, J. P., Gail, M. H., Pee, D., Anderson, S., Redmond, C. K., Benichou, J., & Wieand, H. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1541 · Cited by 765
Self-citationDetermining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
Parmigiani, G., Berry, D. A., & Aguilar, O. (1998) · The American Journal of Human Genetics · doi:10.1086/301670 · Cited by 753
BRCA1 Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer
Couch, F. J., DeShano, M. L., Blackwood, M. A., Calzone, K., Stopfer, J., Campeau, L., Ganguly, A., Rebbeck, T., Weber, B. L., Jablon, L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362002 · Cited by 685
Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
Gail, M. H., Costantino, J. P., Bryant, J., Croyle, R., Freedman, L., Helzlsouer, K., & Vogel, V. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1829 · Cited by 670
Self-citationVariations in Lung Cancer Risk Among Smokers
Bach, P. B., Kattan, M. W., Thornquist, M. D., Kris, M. G., Tate, R. C., Barnett, M. J., Hsieh, L. J., & Begg, C. B. (2003) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.470 · Cited by 642
Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., et al. (1998) · Circulation · doi:10.1161/01.cir.97.18.1876 · Cited by 609
Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., Gumpper, K. L., Scholl, T., Tavtigian, S. V., Pruss, D. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1480 · Cited by 558
Berry, D. A., Iversen, E. S., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., Lerman, C., Watson, P., Lynch, H. T., Hilsenbeck, S. G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.121 · Cited by 505
Memorial Sloan Kettering Cancer Center
(2015) · The SAGE Encyclopedia of Cancer and Society · doi:10.4135/9781483345758.n370 · Cited by 502
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. J., & Easton, D. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600008 · Cited by 495
Colditz, G. A. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.950 · Cited by 487
Self-citationThe BOADICEA model of genetic susceptibility to breast and ovarian cancer
Antoniou, A. C., Pharoah, P. P. D., Smith, P., & Easton, D. F. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602175 · Cited by 467
Frank, T. S., Manley, S. A., Olopade, O. I., Cummings, S., Garber, J. E., Bernhardt, B., Antman, K., Russo, D., Wood, M. E., Mullineau, L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2417 · Cited by 455
Wijnen, J. T., Vasen, H. F. A., Khan, P. M., Zwinderman, A. H., van der Klift, H., Mulder, A., Tops, C., Møller, P., Fodde, R., Menko, F., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390804 · Cited by 396
Shattuck-Eidens, D. (1997) · JAMA · doi:10.1001/jama.1997.03550150046034 · Cited by 374
Harvard Report on Cancer Prevention Volume 4: Harvard Cancer Risk Index
Colditz, G. A., Atwood, K. A., Emmons, K., Monson, R. R., Willett, W. C., Trichopoulos, D., & Hunter, D. J. (2000) · Cancer Causes & Control · doi:10.1023/a:1008984432272 · Cited by 308
Self-citationFreedman, A. N., Graubard, B. I., Rao, S. R., McCaskill-Stevens, W., Ballard-Barbash, R., & Gail, M. H. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.7.526 · Cited by 260
Self-citationThe Prevalence of Common BRCA1 and BRCA2 Mutations among Ashkenazi Jews
Hartge, P., Struewing, J. P., Wacholder, S., Brody, L. C., & Tucker, M. A. (1999) · The American Journal of Human Genetics · doi:10.1086/302320 · Cited by 226
Self-citationNurses' Health Study: Log-Incidence Mathematical Model of Breast Cancer Incidence
Rosner, B., & Colditz, G. A. (1996) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/88.6.359 · Cited by 217
Self-citationPrediction of pathogenic mutations in patients with early-onset breast cancer by family history
Lalloo, F., Varley, J., Ellis, D., Moran, A., O'Dair, L., Pharoah, P., & Evans, D. G. R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12856-5 · Cited by 202
The calculation of breast cancer risk for women with a first degree family history of ovarian cancer
Claus, E. B., Risch, N., & Thompson, W. D. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00666424 · Cited by 193
Selvachandran, S., Hodder, R., Ballal, M., Jones, P., & Cade, D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09549-1 · Cited by 163
Imperiale, T. F., Wagner, D. R., Lin, C. Y., Larkin, G. N., Rogge, J. D., & Ransohoff, D. F. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-12-200312160-00005 · Cited by 156
PRACTICAL GUIDE FOR ESTIMATING RISK FOR FAMILIAL BREAST CANCER
Ottman, R., King, M., Pike, M., & Henderson, B. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90580-9 · Cited by 135
Gilpin, C., Carson, N. L., & Hunter, A. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580408.x · Cited by 115
Risk of familial breast cancer
Anderson, D. E., & Badzioch, M. D. (1985) · Cancer · doi:10.1002/1097-0142(19850715)56:2<383::aid-cncr2820560230>3.0.co;2-0 · Cited by 112
Hartge, P. A., Whittemore, A. S., Itnyre, J., McGowan, L., & Cramer, D. W. (1994) · PubMed · Cited by 83
Self-citationYakeishi, Y., Mori, M., & Enjoji, M. (1990) · Cancer · doi:10.1002/1097-0142(19900815)66:4<812::aid-cncr2820660436>3.0.co;2-1 · Cited by 39
Modeling familial clustered breast cancer using published data.
Jonker, M. A., Jacobi, C. E., Hoogendoorn, W. E., Nagelkerke, N. J. D., de Bock, G. H., & van Houwelingen, H. C. (2003) · PubMed · Cited by 37
Estimation of individualized probabilities of developing breast cancer for Japanese women
Ueda, K., Tsukuma, H., Tanaka, H., Ajiki, W., & Oshima, A. (2003) · Breast Cancer · doi:10.1007/bf02967626 · Cited by 20
Cited by
Decision curve analysis: a novel method for evaluating prediction models
Vickers, A. J., & Elkin, E. B. (2006) · Medical Decision Making · doi:10.1177/0272989x06295361 · Cited by 6,341
“572 • MEDICAL DECISION MAKING/NOV–DEC 2006 technology into clinical management, the development of prognostic and diagnostic models is likely to increase.(1) This lends urgency to the search for appropriate methods to determine the value of such models.”
BackgroundHow To Build and Interpret a Nomogram for Cancer Prognosis
Iasonos, A., Schrag, D., Raj, G. V., & Panageas, K. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9791 · Cited by 3,222
Tice, J. A., Cummings, S. R., Smith-Bindman, R., Ichikawa, L., Barlow, W. E., & Kerlikowske, K. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-5-200803040-00004 · Cited by 537
The LLP risk model: an individual risk prediction model for lung cancer
Cassidy, A., Myles, J. P., van Tongeren, M., Page, R. D., Liloglou, T., Duffy, S. W., & Field, J. K. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604158 · Cited by 490
Breast Tissue Composition and Susceptibility to Breast Cancer
Boyd, N. F., Martin, L. J., Bronskill, M., Yaffe, M. J., Duric, N., & Minkin, S. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq239 · Cited by 478
Metadata
- Authors
- Freedman, A. N., Seminara, D., Gail, M. H., Hartge, P., Colditz, G. A., Ballard-Barbash, R., & Pfeiffer, R. M.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-18
- Volume
- 97
- Issue
- 10
- Pages
- 715-723
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2154184032
- Cited by
- 267
- References
- 39
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.